Clinical Trials for Melanoma

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT ID: NCT05053230

The IM@HOME clinical trial is studying a program that offers virtual mind-body therapies to help people with certain types of cancer, including head and neck cancer, ovarian cancer, and melanoma, a...

Clinical Genetics Branch Eligibility Screening Survey

NCT ID: NCT07005297

The Clinical Genetics Branch (CGB) is looking for people to participate in research studies focused on specific genetic conditions that can increase the risk of cancer, such as melanoma and various...

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT ID: NCT05600933

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT ID: NCT00001823

This clinical trial, led by the National Cancer Institute Surgery Branch (NCI-SB), is exploring new experimental treatments for various types of cancer, including synovial cell cancer, melanoma, co...

PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients

NCT ID: NCT06906822

The PLUG-IN trial is studying a new treatment approach for patients with advanced melanoma who have not responded to standard therapies. Specifically, it looks at combining two drugs: pembrolizumab...

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

NCT ID: NCT06204991

This clinical trial is investigating a new treatment called ADP-TILIL7 for patients with advanced melanoma, specifically those whose cancer cannot be surgically removed or has spread to other parts...

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

NCT ID: NCT05068102

This clinical trial is looking at how two medicines, BI 765063 and BI 770371, are taken up by tumors in adults with advanced types of cancer, such as head and neck cancer, melanoma, or non-small ce...

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT ID: NCT07070518

This clinical trial is testing a new medicine called GV20-0251 to see if it can help adults with advanced solid tumors—types of cancer that form solid masses in the body—who have not responded to s...

National Cancer Institute "Cancer Moonshot Biobank"

NCT ID: NCT04314401

The "Cancer Moonshot Biobank" is a clinical trial that aims to gather blood and tissue samples from patients diagnosed with various types of cancer, including advanced stages of breast cancer, lung...

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT ID: NCT05208762

This clinical trial is studying a new drug called PF-08046054/SGN-PDL1V to see how safe it is for patients with advanced solid tumors, which are cancers that have spread in the body or cannot be su...

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

NCT ID: NCT06870487

This clinical trial is designed to investigate a new medicine called PF-08046032 for adults with advanced cancers, specifically certain types of lymphomas and solid tumors. The study aims to unders...

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

NCT ID: NCT06799533

This clinical trial is studying a new medicine called PF-08046031, which is being tested for safety and effectiveness in treating advanced melanoma and other solid tumors. These are types of cancer...

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05581004

This clinical trial is testing a new treatment called RO7502175, both on its own and in combination with another medication called atezolizumab. The study is designed for adults who have locally ad...

DESTINY-PANTUMOUR04

NCT ID: NCT07124000

This clinical trial, called DESTINY-PANTUMOUR04, is studying a medicine called T-DXd to see how well it works in people with certain advanced cancers that have a specific marker called HER2-positiv...

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT ID: NCT03829254

This clinical trial is studying a new treatment called NUC-7738 for patients with advanced cancers, including solid tumors and lymphoma. The trial is divided into two phases. In the first phase, re...

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-positive Cancers.

NCT ID: NCT05770544

The DETERMINE Trial is studying a medication called entrectinib to see if it can help treat various types of cancers that have a specific genetic change known as ROS1 gene fusion. While entrectinib...

A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

NCT ID: NCT05912244

This clinical trial is studying a new treatment for people with melanoma, a type of skin cancer that has spread and cannot be surgically removed. The researchers want to see if two experimental vac...

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

NCT ID: NCT06054555

This clinical trial is studying a new treatment called ABP 206 to see how it compares to an existing medication known as OPDIVO® (Nivolumab) for patients with advanced melanoma that cannot be surgi...

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

NCT ID: NCT04895709

This clinical trial is studying a new treatment called BMS-986340 for patients with advanced solid tumors, which include various types of cancers like cervical cancer, lung cancer, and breast cance...

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT ID: NCT05108298

This clinical trial is focused on improving how young adults and adolescents with cancer report their experiences and symptoms during treatment. The study aims to find out if giving participants a ...